𩺠å
§ç§å°ç§èåç
1ïžâ£ Autonomic Storm Management
- Week 2-3 of clinical course = peak autonomic instability â äž»èŠæ»å
- BP/HR swings, 倧æ±, arrhythmia
- Magnesium sulfate â 第äžéžæ control
- β-blocker (esmolol) â labile BP; é¿å
long-acting (overshoot hypotension)
- Clonidine, dexmedetomidine â α-2 agonist
- é¿ fluid overload (autonomic äžç©© â flash pulmonary edema)
- ICU central monitoring
2ïžâ£ Magnesium Sulfate â Thwaites Trial
- Lancet 2006 Vietnam RCT
- äžé mortality äœæž BZD çšé, æž ventilation need
- 4 g IV bolus â 1.5-3 g/h infusion (titrate)
- Monitor DTR (loss â toxic)
3ïžâ£ çºä»éºŒç«è preventable äœä»èŠ
- è幎人 wane immunity
- è¡å, IDU, æªæ¥çš®ç§»æ°
- Wound å¿œç¥ (å°€å
¶ puncture)
- ç§é«åž« hint: 50 æ²åŸç
äººéœ ask Td å²; DM/è
dialysis ç
人ç¹å¥ wane
4ïžâ£ éå¥ Diagnosis
- Strychnine poisoning: é¡äŒŒ spasm äœ no trismus, relaxation between spasms
- Dystonic reaction: phenothiazine, metoclopramide â IV benadryl ç«å» reverses
- Stiff person syndrome: chronic, anti-GAD Ab
- Hypocalcemic tetany: Chvostek/Trousseau, Ca low
- Encephalitis with rigidity: NMDA, ADEM
5ïžâ£ Neonatal Tetanus Elimination
- WHO MNT èšç«
- æ¯ vaccine in pregnancy + æž
æœååš©
- 倧å¹
æž cases äœä» endemic in African + Asian rural
6ïžâ£ å¥ä¿ / Taiwan
- DTaP series å
¬è²» †5 yr
- 11-12 yr Tdap å
¬è²»
- 50+ Tdap booster å
¬è²» (2022-)
- å婊 27-36 wk Tdap (æšèŠ, èªè²»æå
¬è²» by county)